Ambrx Biopharma
Stock Forecast, Prediction & Price Target
Ambrx Biopharma Financial Estimates
Ambrx Biopharma Revenue Estimates
Ambrx Biopharma EBITDA Estimates
Ambrx Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $13.67M N/A | $7.45M -45.46% | $7.40M -0.71% | Avg: $4.59M Low: $6.43M High: $2.65M avg. -37.92% | |||
Net Income
% change YoY
| $-17.83M N/A | $-68.28M -282.80% | $-77.99M -14.21% | Avg: $-111.48M Low: $-61.76M High: $-6.56M avg. -42.93% | |||
EBITDA
% change YoY
| $-11.17M N/A | $-62.27M -457.37% | $-55.78M 10.40% | Avg: $-4.38M Low: $-6.14M High: $-2.53M avg. 92.14% | |||
EPS
% change YoY
| -$0.47 N/A | -$3.34 -610.63% | -$2.02 39.52% | Avg: -$0.89 Low: -$1.6 High: -$0.17 avg. 56.18% | |||
Operating Expenses
% change YoY
| $26.78M N/A | $71.87M 168.34% | $74.14M 3.14% | Avg: $3.54M Low: $4.96M High: $2.04M avg. -95.21% | |||
FAQ
What is Ambrx Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -42.93% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -61.76M, average is -111.48M and high is -6.56M.
What is Ambrx Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -37.92% in 2025-2025.
We have gathered data from 9 analysts. Their low revenue estimate is $6.43M, average is $4.59M and high is $2.65M.
What is Ambrx Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 56.18% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.6, average is -$0.89 and high is $-0.17.